A new $15 million initiative between Pfizer and the American Cancer Society (ACS) aims to tackle one of the most pressing issues in health at the moment – unequal access to care.
The three-year ‘Change the Odds’ programme is being funded by Pfizer, with the objective of improving awareness and access to cancer screenings, clinical trial opportunities, and patient support programmes for “medically underrepresented communities across the US.”
